Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2018)

Relmada Therapeutics (RLMD) has 5 years of Debt Ratio data on file, last reported at 4.95 in Q3 2018.

• Debt Ratio for Q3 2018 came in at 4.95, up 769.64% year-over-year; the trailing twelve-month figure through Sep 2018 was 4.95 (up 769.64% YoY), and the FY2018 annual result was 2.25, up 3526.03% from the prior year.
• Debt Ratio advanced to 4.95 in Q3 2018 per RLMD's latest filing, from 2.25 in the prior quarter.
• Over five years, Debt Ratio peaked at 4.95 in Q3 2018 and troughed at 0.05 in Q1 2016.
• A 5-year average of 0.86 and a median of 0.57 in 2017 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2016 and 2018: Debt Ratio tumbled 94.5% in 2016, then jumped 3526.03% in 2018.
• A 5-year view of Debt Ratio shows it stood at 0.81 in 2014, then slumped by 89.25% to 0.09 in 2015, then fell by 3.44% to 0.08 in 2016, then jumped by 797.45% to 0.75 in 2017, then surged by 556.23% to 4.95 in 2018.
• Business Quant data shows RLMD's Debt Ratio at 4.95 in Q3 2018, 2.25 in Q2 2018, and 1.15 in Q1 2018.